Amgen to lay off hundreds, including in Thousand Oaks
Biotech giant Amgen is in the process of laying off hundreds of workers, including as many as 100 at its Thousand Oaks headquarters. According to a spokesperson for the company, approximately 500 workers will be let go beginning April 2. Less than 20% of those workers are located in Thousand Oaks. Amgen employs around 22,000 Read More →
Read More →Dubroff: Today’s tech titans owe a debt to Dave Power
Big data. Brand value. Customer satisfaction. In the 21st century, these are crucial elements for success in business and they have driven the growth of the technology titans that dominate our everyday lives. But Jeff Bezos, Tim Cook, Mark Zuckerberg and countless others owe a debt to J.D. “Dave” Power, who laid out the design Read More →
Read More →
Amgen shares slip after projections of flat 2021 sales
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →PennyMac reports earnings jump, tops $2B in income in 2020
PennyMac Financial Services hit a record high with pretax income of more than $2 billion last year as the company saw a sharp increase in both its fourth quarter and year-end results. The Westlake Village-based mortgage firm reported a net income of $452.8 million for the fourth quarter of 2020, or $5.97 per share on Read More →
Read More →Amgen reports rising revenue, warns of flat 2021
Amgen, one of the world’s largest biotech companies, saw rising revenue in the fourth quarter of 2020, but the COVID-19 pandemic could dampen the outlook for the company and its investors in 2021, according to earnings released Feb. 2. The Thousand Oaks-based biotech firm had $6.6 billion in revenue in the fourth quarter, a 7% Read More →
Read More →Inphi reports record revenue, declining losses in 2020
Inphi, a Santa Clara semiconductor company with sizable operations in Thousand Oaks, reported record revenue for the fourth quarter of 2020 and a smaller net loss than the same quarter a year earlier. Inphi, which reported its earnings on Feb. 2, is in the midst of being acquired by Marvell Technology Group, a larger competitor Read More →
Read More →Arcutis stock soars on drug trial news; company announces $150M capital raise
Stock of Arcutis Biotherapeutics, a Westlake Village-based company developing dermatological treatments, shot up more than 30% on Feb. 1 after the company released positive results from a recent clinical trial. Later in the day, Arcutis said it plans to sell $150 million worth of its common stock. Before stock trading opened, the company announced positive Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
